Summary
Transforming growth factor-β (TGF-β) is a family of 25-kDa dimeric proteins that regulate the cellular growth and differentiation, the formation of extracellular matrix, and the immune function. TGF-βs belong to a larger family of structurally related proteins known as the TGF-β superfamily, which includes activins and bone morphogenetic proteins. TGF-β exerts the effects through binding to type I (TβR-I; 53 kDa) and type II (TβR-II; 75 kDa) serine/threonine kinase receptors. Overall structures of TβR-I and TβR-II are similar to each other. Preceding the kinase domain of TβR-I, there is a region termed the GS domain, which is conserved in type I receptors, but not in type II receptors. After ligand binding, TβR-I and TβR-II form a heteromeric receptor complex, which is most likely a heterotetramer composed of two molecules each of TβR-I and TβR-II. TβR-II transphosphorylates the GS domain of TβR-I, which then activates the TβR-I kinase and transduces signals. By yeast two-hybrid system, several proteins which interact with type I or type II receptors, and possibly transduce the signals for TGF-p, have been isolated. Mutations in the TβR-II gene have been identified in several carcinoma cells, which suggests that loss of the TβR-II protein is one of the mechanisms by which cancer cells acquire resistance to the growth inhibitory activity of TGF-β.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Miyazono K, ten Dijke P, Ichijo H, Heldin C-H (1994) Receptors for transforming growth factor-β. Adv Immunol 55: 181–220
Kingsley DM (1994) The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8: 133–146
Roberts AB, Sporn MB (1990) The transforming growth factor-βs. In: Sporn MB, Roberts AB (eds) Peptide growth factors and their receptors, part I. Springer-Verlag, Berlin, pp 419–472
Sporn MB, Roberts AB (1992) Transforming growth factor-β: Recent progress and new challenges. J Cell Biol 119: 1017–1021
Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T (1992) Targeted disruption of the mouse transforming growth factor-βl gene results in multifocal inflammatory disease. Nature 359: 693–699
Kulkarni AB, Huh C-G, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S (1993) Transforming growth factor βl null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90: 770–774
Mathews LS (1994) Activin receptors and cellular signaling by the receptor serine kinase family. Endocrine Rev 15: 310–325
Murata M, Eto Y, Shibai H, Sakai M, Muramatsu M (1988) Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin βA chain. Proc Natl Acad Sci USA 85: 2434–2438
Wozney JM (1989) Bone morphogenetic proteins. Prog Growth Factor Res 1: 267–280
Reddi AH (1992) Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Curr Opin Cell Biol 4: 850–855
Reddi AH (1994) Bone and cartilage differentiation. Curr Opin Genet Develop 4: 737–744
Winnier G, Blessing M, Labosky PA, Hogan BL (1995) Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9: 2105–2116
Miyazono K, ten Dijke P, Yamashita H, Heldin C-H (1994) Signal transduction via serine/threonine kinase receptors. Seminars Cell Biol 5: 389–398
Massagué J, Attisano L, Wrana JL (1994) The TGF-β family and its composite receptors. Trends Cell Biol 4: 172–178
Derynck R (1994) TGF-β-receptor-mediated signaling. Trends Biochem Sci 19: 548–553
ten Dijke P, Miyaono K, Heldin C-H (1996) Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr Opin Cell Biol (in press)
ten Dijke P, Ichijo H, Franzén P, Schulz P, Saras J, Toyoshima H, Heldin C-H, Miyazono K (1993) Activin receptor-like kinases; A novel subclass of cell surface receptors with predicted serine/threonine kinase activity. Oncogene 8: 2879–2887
Franzén P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C-H, Miyazono K (1993) Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 75: 781–792
ten Dijke P, Yamashita H, Ichijo H, Franzén P, Laiho M, Miyazono K, Heldin C-H (1994) Characterization of type I receptors for transforming growth factor-13 and activin. Science 264: 101–104
Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA, Lodish HF (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775–785
Wrana JL, Attisano L, Cârcamo J, Zentella A, Doody J, Laiho M, Wang X-F, Massagué J (1992) TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71: 1003–1014
Letsou A, Arora K, Wrana JL, Simin K, Twombly V, Jamal J, Staehling-Hampton K, Hoffmann FM, Gelbart WM, Massagué J, O’Connor MB (1995) Drosophila Dpp signaling is mediated by the punt gene product: A dual ligand-binding type II receptor of the TGFβ receptor family. Cell 80: 899–908
ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin C-H, Miyazono K (1994) Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269: 16985–16988
Koenig BB, Cook JS, Wolsing DH, Ting J, Tiesman JP, Correa PE, Olson CA, Pecquet AL, Ventura F, Grant RA, Chen G-X, Wrana JL, Massagué J, Rosenbaum JS (1994) Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 14: 5961–5974
Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin C-H, Miyazono K (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92: 7632–7636
Liu F, Ventura F, Doody J, Massagué J (1995) Human type II receptor for bone morphogenetic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 15: 3479–3486
Nohno T, Ishikawa T, Saito T, Hosokawa K, Noji S, Hanse Wolsing D, Rosenbaum JS (1995) Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptor. J Biol Chem 270: 22522–22526
WranaJL, Attisano L, Wieser R, Ventura F, Massagué J (1994) Mechanism of activation of the TGF-β receptor. Nature 370: 341–347
Henis YI, Moustakas A, Lin HY, Lodish HF (1994) The types II and III transforming growth factor-β receptors form homo-oligomers. J Cell Biol 126: 139–154
Chen R-H, Derynck R (1994) Homomeric interactions between type II transforming growth factor-β receptors. J Biol Chem 269: 22868–22874
Yamashita H, ten Dijke P, Franzén P, Miyazono K, Heldin C-H (1994) Formation of heterooligomeric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem 269: 20172–20178
Okadome T, Yamashita H, Franzén P, Morén A, Heldin C-H, Miyazono K (1994) Distinct roles of the intracellular domains of transforming growth factor-β type I and type II receptors in signal transduction. J Biol Chem 269: 30753–30756
Vivien D, Attisano L, Wrana JL, Massagué J (1995) Signaling activity of homologous and heterologous transforming growth factor-13 receptor kinase complexes. J Biol Chem 270: 7134–7141
Franzén P, Heldin C-H, Miyazono K (1995) The GS domain of the transforming growth factor-β type I receptor is important in signal transduction. Biochem Biophys Res Commun 207: 682–689
Wieser R, Wrana JL, Massagué J (1995) GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J 14: 2199–2208
Saitoh M, Nishitoh H, Amagasa T, Miyazono K, Takagi M, Ichijo H (1996) Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-β. J Biol Chem (in press)
Yamashita H, Okadome T, Franzén P, ten Dijke P, Heldin C-H, Miyazono K (1995) A rat pituitary tumor cell line (GH3) expresses type I and type II receptors and other cell surface binding protein(s) for transforming growth factor-β. J Biol Chem 270: 770–774
Moustakas A, Takumi T, Lin HY, Lodish HF (1995) GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor β and activinA. J Biol Chem 270: 765–769
Cârcamo J, Weis FMB, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J (1994) Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol Cell Biol 14: 3810–3821
Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin C-H, Miyazono K (1995) Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol 130: 217–226
Wang T, Donahoe PK, Zervos AS (1994) Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science 265: 674–676
Kawabata M, Imamura T, Miyazono K, Engel ME, Moses HL (1995) Interaction of the TGFβ type I receptor with farnesyl-protein transferase-a. J Biol Chem (in press)
Chen R-H, Miettinen PJ, Maruoka EM, Choy L, Derynck R (1995) A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature 377: 548–552
Chen R-H, Moses HL, Maruoka EM, Derynck R, Kawabata M (1995) Phosphorylationdependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-1 receptors. J Biol Chem 270: 12235–12241
Kawabata M, Chytil A, Moses HL (1995) Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-13 receptor. J Biol Chem 270: 5625–5630
Yamada N, Kato M, Yamashita H, Nistér M, Miyazono K, Heldin C-H, Funa K (1995) Enhanced expression of transforming growth factor-13 and its type I and type II receptors in human glioblastoma tissues. Int J Cancer 62: 386–392
Kadin ME, Cavaille-Coll MW, Gertz R, Massagué J, Cheifetz S, George D (1994) Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc Natl Acad Sci USA ‘81: 6002–6006
Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts AB, Sporn MB (1994) Genetic changes in the transforming growth factor β (TGFβ) type II receptor gene in human gastric cancer cells: correlation with sensitivitiy to TGFβ. Proc Natl Acad Sci USA 91: 8772–8776
Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV (1995) Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability. Science 268: 1336–1338
Lu S-L, Akiyama Y, Nagasaki H, Saitoh K, Yuasa Y (1995) Mutations of the transforming growth factor-13 type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. Biochem Biophys Res Commun 216: 452–457
Garrigue-Antar L, Munoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF, Reiss M (1995) Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res 55: 3982–3987
Wang J, Sun L, Myeroff L, Wang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JKV, Brattain MG (1995) Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270: 22044–22049
Higgins DG, Sharp PM (1989) Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl Biosci 5: 151–153
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Tokyo
About this paper
Cite this paper
Miyazono, K. (1996). TGF-β Receptors and Signal Transduction. In: Ikehara, S., Takaku, F., Good, R.A. (eds) Bone Marrow Transplantation. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68320-9_15
Download citation
DOI: https://doi.org/10.1007/978-4-431-68320-9_15
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68322-3
Online ISBN: 978-4-431-68320-9
eBook Packages: Springer Book Archive